The latent transforming growth factor β binding protein (LTBP) family

Biochemical Journal

Volumn 352, Issue 3, 2000, Pages 601-610

  Oklu R ^a   Hesketh, R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Atherosclerosis; Cancer; Fibrillin; Marfan's syndrome; TGF

Indexed keywords

BINDING PROTEIN; CYTOKINE; FIBRILLIN; PROTEIN LTBP; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CANCER; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; MAMMAL CELL; MARFAN SYNDROME; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN STRUCTURE; REVIEW; SPLICEOSOME;

ALTERNATIVE SPLICING; ANIMALS; ARTERIOSCLEROSIS; CARRIER PROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LATENT TGF-BETA BINDING PROTEINS; MULTIGENE FAMILY; NEOPLASMS; ORGAN SPECIFICITY; TRANSFORMING GROWTH FACTOR BETA;

MAMMALIA;

EID: 0034672359     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3520601     Document Type: Review

References (131)

1. Transforming growth factor-β1, factor-β2, and factor-β3 secreted by a human glioblastoma cell-line - Identification of small and different forms of large latent complexes
2. Latent high molecular-weight complex of transforming growth factor-β1 - Purification from human-platelets and structural characterization
3. Latent transforming growth factor-β from human-platelets - A high molecular-weight complex containing precursor sequences
4. 1 with multiple repeat sequences
5. Purification and structural analysis of a latent form of transforming growth factor-β from rat platelets
6. Molecular-cloning of the large subunit of transforming growth-factor type β masking protein and expression of the mRNA in various rat tissues
7. Efficient association of an amino-terminally extended form of human latent transforming growth factor β-binding protein with the extracellular matrix
8. Bovine latent transforming growth factor β1-binding protein-2: Molecular cloning, identification of tissue isoforms, and immunolocalization to elastin-associated microfibrils
9. Identification and characterization of LTBP-2, a novel latent transforming growth factor-β-binding protein
10. Analysis of the human gene encoding latent transforming growth factor-β-binding protein-2
11. Mouse latent TGF-β binding protein 2: Molecular cloning and developmental expression
12. Isolation of a novel latent transforming growth factor β-binding protein gene (LTBP-3)
13. Mapping of human and murine genes for latent TGF-beta binding protein-2 (LTBP2)
14. Sequence and expression of a novel member (LTBP-4) of the family of latent transforming growth factor-β binding proteins
15. The transforming growth-factor-β family
16. Growth factors from murine sarcoma virus-transformed cells
17. Transforming growth factors: Isolation of polypeptides from virally and chemically transformed ceils by acid/ethanol extraction
18. Sarcoma growth factors from conditioned medium of virally transformed cells is composed of both type α and type β transforming growth factors
19. Transforming growth factor beta is a modulator of platelet-derived growth factor action in vascular smooth muscle cells: A possible role for catalase activity and glutathione peroxidase activity
20. Analysis of interleukin (IL)-1 β and transforming growth factor (TGF)-β-induced signal transduction pathways in IL-2 and TGF-β secretion and proliferation in the thymoma cell line EL4.NOB-1
21. Transforming growth-factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular-matrix
22. Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro
23. Transforming growth-factor type β induces monocyte chemotaxis and growth-factor production
24. T-cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth-factor-β
25. Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: Involvement of transforming growth factor β1
26. Generational analysis reveals that TGF-β 1 inhibits the rate of angiogenesis in vivo by selective decrease in the number of new vessels
27. Role of active and latent transforming growth-factor-β in bone-formation
28. Absence of TGF-β receptors and growth inhibitory responses in retinoblastoma cells
29. Growth-inhibition by transforming growth factor-β (TGF-β) type-I is restored in TGF-β-resistant hepatoma-cells after expression of TGF-β receptor type II cDNA
30. 3 iin human small-cell lung-cancer cell-lines
31. Genetic changes in the transforming growth-factor-beta (TGF-β) type-II receptor gene in human gastric-cancer cells: Correlation with sensitivity tO growth-inhibition by TGF-β
32. Loss of expression Of transforming growth-factor-β in skin and skin tumors is associated with hyperproliferation and a high-risk for malignant conversion
33. Increased mannose 6-phosphate insulin-like growth factor-receptor and transforming growth-factor-β-1 levels during monoterpene-induced regression of mammary-tumors
34. Mechanisms of disease: Role of transforming growth factor β in human disease
35. Expression of transforming growth-factor-β type-II receptor leads to reduced malignancy in human breast-cancer MCF-7 cells
36. Disruption of the antiproliferative TGF-β signaling pathways in human pancreatic cancer cells
37. Mutational inactivation of transforming growth factor β receptor type II in microsatellite stable colon cancers
38. Cyclosporine induces cancer progression by a cell-autonomous mechanism
39. TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice
40. Pivotal role for TGF-β in atherogenesis
41. Activation of transforming growth-factor-β is inhibited in transgenic apolipoprotein(a) mice
42. The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis
43. TGF-β in blood: A complex problem
44. Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5′ end
45. Independent promoters regulate the expression of two amino terminally distinct forms of latent transforming growth factor-β binding protein-1 (LTBP-1) in a cell type-specific manner
46. Identification and characterization of an 8 cysteine repeat of the latent transforming growth factor-β binding protein-1 that mediates bonding to the latent transforming growth factor-β
47. Association of the small latent transforming growth factor-β with an eight cysteine repeat of its binding protein LTBP-1
48. 8-Cysteine TGF-BP structural motifs are the site of covalent binding between mouse LTBP-3, LTBP-2, and latent TGF-β 1
49. Solution structure of the transforming growth factor β-binding protein-like module, a domain associated with matrix fibrils
50. Extracellular-matrix. 4. The elastic fiber
51. Fibrillin, a new 350-kd giycoprotein, is a component of extracellular microfibrils
52. Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices
53. 2+ binding of latent transforming growth-factor-β1 binding protein
54. Calcium determines the shape of fibrillin
55. Mutations in calcium-binding epidermal growth factor modules render fibrillin-1 susceptible to proteolysis - A potential disease-causing mechanism in Marfan syndrome
56. Identification and characterization of a new latent transforming growth factor-β-binding protein LTBP-4
57. Loss of a consensus heparin binding site by alternative splicing of latent transforming growth factor-β binding protein-1
58. Expression of alternatively spliced human latent transforming growth factor β binding protein-1
59. Isoforms and splice variant of transforming growth factor β-binding protein in rat hepatic stellate cells
60. Alternative splicing of LTBP-3
61. Characterisation of four novel fibrillin-1 (FBN1) mutations in Marfan syndrome
62. The skipping of constitutive exons in vivo induced by nonsense mutations
63. Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome
64. Marfan like phenotypes caused by mutations in LTBP-2
65. Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-β
66. VEGF(145), a secreted vascular endothelial growth factor isoform that binds to extracellular matrix
67. Specific EGF repeats of Notch mediate interactions with Delta and Serrate - Implications for Notch as a multifunctional receptor
68. Expression of alternatively spliced epidermal growth factor-like domains in aggrecans of different species - Evidence for a novel module
69. Structural characterization and alternate splicing of the gene encoding the preadipocyte EGF-like protein PREF-1
70. Mutant fibrillin-1 monomers lacking EGF-like domains disrupt microfibril assembly and cause severe Marfan syndrome
71. A role of the latent TGF-β1-binding protein in the assembly and secretion of TGF-β1
72. Characterization and autoregulation of latent transforming growth factor beta (TGFβ) complexes in osteoblast-like cell lines - Production of a latent complex lacking the latent TGFβ binding protein
73. 3 enhances the expression of transforming growth factor β1 and its latent form binding protein in cultured breast-carcinoma cells
74. Retention of the transforming growth factor-β1 precursor in the Golgi-complex in a latent endoglycosidase H-sensitive form
75. Adult human aortic smooth-muscle cells in culture produce active TGF-β
76. Proliferation of human aortic vascular smooth-muscle cells in culture is modulated by active TGF-β
77. Inhibition of endothelial-cell movement by pericytes and smooth muscle cells - Activation of a latent transforming growth factor-β1-like molecule by plasmin during co-culture
78. Role of the latent TGF-β binding-protein in the activation of latent TGF-β by cocultures of endothelial and smooth-muscle cells
79. Cellular activation of latent transforming growth-factor-β requires binding to the cation-independent mannose 6-phosphate insulin-like growth-factor type-II receptor
80. Interactions of recombinant and platelet transforming growth factor-β1 precursor with the insulin-like growth factor II mannose 6- phosphate receptor
81. Deficient transforning growth factor-β1 activation and excessive insulin-like growth factor II (IGFII) expression in IGFII receptor-mutant tumors
82. Identification of mannose 6-phosphate in two asparagine-linked sugar chains of recombinant transforming growth factor-β 1 precursor
83. Recombinant type 1 transforming growth factor β precursor produced in Chinese hamster ovary cells is glycosytated and phosphorylated
84. Role for carbohydrate structures in TGF-β-1 latency
85. Latent transforming growth-factor-β1 and its binding-protein are components of extracellular-matrix microfibrils
86. The cutaneous microfibrillar apparatus contains latent transforming growth factor-β binding protein-1 (LTBP-1) and is a repository for latent TGF-β1
87. Latent transforming growth factor-β: Structural features and mechanisms of activation
88. The mechanism for the activation of latent TGF-β during coculture of endothelial-cells and smooth-muscle cells - Cell-type-specific targeting of latent TGF-β to smooth-muscle cells
89. Role of carbohydrate structures in the binding of β1-latency-associated peptide to ligands
90. Latent transforming growth-factor-β1 associates to fibroblast extracellular matrix via latent TGF-β binding protein
91. Regulation of cell surface tissue transglutaminase: Effects on matrix storage of latent transforming growth factor-beta binding protein-1
92. Requirement for transglutaminase in the activation of latent transforming growth-factor-β in bovine endothelial-cells
93. Characterization of latent TGF-β activation by murine peritoneal macrophages
94. Dual role for the latent transforming growth-factor-β binding-protein in storage of latent TGF-β in the extracellular-matrix and as a structural matrix protein
95. Extracellular fibrillar structure of latent TGFβ binding protein 1: Role in TGFβ-dependent endothelial-mesenchymal transformation during endocardial cushion tissue formation in mouse embryonic heart
96. Proliferation of human smooth-muscle cells promoted by lipoprotein(a)
97. Physiological consequences of loss of plasminogen-activator gene-function in mice
98. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
99. Developmental expression of latent transforming growth factor β binding protein 2 and its requirement early in mouse development
100. Thrombospondin-1 s a major activator of TGF-β 1 in vivo
101. Recombinant latent transforming growth factor β-binding protein 2 assembles to fibroblast extracellular matrix and is susceptible to proteolytic processing and release
102. Production of transforming growth factor-β1 during renair of arterial injury
103. In vivo effect of TGF-β1 - Enhanced intimal thickening by administration of TGF-β1 in rabbit arteries injured with a balloon catheter
104. Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth
105. Direct transfer of transforming growth-factor-β1 gene into arteries stimulates fibrocellular hyperplasia
106. Overexpression of transforming growth factor β1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia
107. Antibodies against transforming growth factor-β1 suppress intimal hyperplasia in a rat model
108. Transforming growth-factor-β decreases the rate of proliferation of rat vascular smooth-muscle cells by extending the G(2) phase of the cell-cycle and delays the rise in cyclic AMP before entry into M-phase
109. Transforming growth-factor-β and the protection from cardiovascular injury hypothesis
110. Tamoxifen inhibits arterial accumulation of LDL degradation products and progression of coronary artery atherosclerosis in monkeys
111. Tamoxifen elevates transforming growth-factor-β and suppresses diet-induced formation of lipid lesions in mouse aorta
112. Tamoxifen decreases cholesterol sevenfold and abolishes lipid lesion development in apolipoprotein E knockout mice
113. Fatal myocardial-infarction in the Scottish adjuvant tamoxifen trial
114. Localization of transforming growth factor β1 precursor and latent TGF-β1 binding protein in colorectal adenomas
115. Lack of the latent transforming growth-factor-β binding-protein in malignant, but not benign prostatic tissue
116. Expression of transforming growth factors β1,β2,β3 in neuroendocrine tumors of the digestive system
117. Different expression of transforming growth factor β(1) in pancreatic ductal adenocarcinoma and cystic neoplasms
118. 1 binding protein TGFβ type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms
119. Immunoelectron microscopic localization of transforming growth factor β1 and latent transforming growth factorβ1 binding protein in human gastrointestinal carcinomas: Qualitative difference between cancer-cells and stromal cells
120. Transforming growth factor β1 and its latent form binding protein-1 associate with elastic fibres in human dermis: Accumulation in actinic damage and absence in anetoderma
121. Localization of transforming growth-factor-β-1 and its latent binding-protein in human chronic-pancreatitis
122. Enhanced expression of transforming growth factor-βs and transforming growth factor-β type II receptor in the synovial tissues of patients with rheumatoid arthritis
123. Roles of TGF β and latent TGF β-binding protein in glomerulosclerosis induced by two consecutive injections of monoclonal antibody 1-22-3 in rats
124. Immunohistochemical localization of latent transforming growth factor-β binding protein in IgA nephropathy
125. Matrix-associated latent TGF-β with latent TGFβ binding protein in the progressive process in adriamycin-induced nephropathy
126. Transforming growth factor-beta 1 in hypertensive renal injury in Dahl salt-sensitive rats
127. Anti-latent TGF-β binding protein-1 antibody or synthetic oligopeptides inhibit extracellular matrix expression induced by stretch in cultured rat mesangial cells
128. Expression of transforming growth factor-β1 and its relation to endomysial fibrosis in progressive muscular dystrophy
129. Involvement of transforming growth factor-β in the formation of fibrotic lesions in carcinoid heart disease
130. Local production and localization of transforming growth factor-beta in tuberculous pleurisy
131. Assignment of the gene encoding the latent TGF-β1-binding protein (LTBP1) to human chromosome 2, region p12 q22